The skin is one of the largest organs of the body and its importance is reflected in its blood supply, which in health amounts to about a quarter of the cardiac output and in inflammation to considerably more (Fox et al. 1965) . It contains
many different cell types, some of which are peculiar to the skin. The specialized keratinocytes are in a highly active state, the epidermis they comprise renewing itself once every 28 days in normal people and at up to ten times that rate in some diseases, including psoriasis (Weinstein & Frost 1968) . Even fibres of the relatively inert skin connective tissue have a finite turnover time, and new formation, as well as degradation, continues throughout life: the identification of the various defects in genetically-determined enzymedependent steps in collagen . metabolism responsible for the different types of the Ehlers-Danlos syndrome (Pinnell 1982) is an example of how work on the skin has led to a rational biochemical classification of a disease group which previously could be subdivided only on the basis of clinical differences.
The skin cells take part, with others, in a large number of metabolic reactions, abnormalities of which can lead to disease. Sometimes this is apparent in all the tissues with the defect, but, on other occasions, the manifestation of the disease needs an environmental factor such as ultraviolet light as well, and in such cases the skin alone shows the clinical abnormality. For instance, the consequences of the defects of DNA repair (Cleaver 1968), which are found in a number of tissues in xeroderma pigmentosum, are for the most part confined to the skin and are most marked of all in skin which is habitually , light-exposed.
Many hormones and pharmacologically-active substances influence the skin as they circulate through it, or affect it in a less immediate way. Thus, histamine in mastocytosis, and serotonin in the carcinoid syndrome, affect its vasculature; growth hormone and corticosteroids alter its collagen; adrenocorticotrophic hormone-like peptides affect its melanin content.
The skin is a favourite site for various deposits in metabolic disease. It seems sometimes, perhaps because of its structure, to have a special 'affinity' for these, though another possible factor is its rich blood supply. Lipids, mucin, amyloid, iron, calcium, urates and many other substances are 0141-0768j83j090719--{)3/$OI.00jO deposited there. They do not necessarily form static deposits but can remain part of a 'pool' from which some of them are removable by appropriate manipulations of blood and other tissue levels. For example, in favourable conditions even some large xanthomata regress when the patient is treated with a low-fat diet (Vermeer et al. 1982) .
The skin plays a unique and clinically important role in producing vitamin D 3 from its provitamin in the presence of ultraviolet light. It also has the ability to metaboliie androgens and corticosteroids, though the physiological significance of the skin's contribution to the overall metabolism of these hormones is not known. The influence of skin on drug metabolism is an interesting and almost unexplored field.
It is established that rashes themselves, particularly extensive eczema and psoriasis, can influence metabolism in other organs (Shuster 1967) . Although this seemed heresy at the time, in retrospect it is not surprising that widespread inflammatory skin disease, as in erythroderma, can lead to heart failure (Shuster 1963), leaky skin capillaries can contribute to hypoalbuminaemia (Marks & Shuster 1966) , and increased epidermal cell proliferation can cause hyperuricaemia (Marks 1971) . Some metabolic abnormalities secondary to eczema and psoriasis are less easy to understand: they are numerous and diverse and include disturbances of vitamin C, folate, iron, zinc and protein metabolism, as wen as steatorrhoea and gynaecomastia. The clinical importance of some of them is considerable, and the prognosis of complications of erythroderma has been improved by understanding their mechanism (Marks 1982) . The importance of others, apart from their great interest, lies in recognizing them for what they are, thus avoiding over-investigation and inappropriate treatment.
Thus the skin is much more than the inert mirror of internal processes it was once thought to be, though, by virtue of its accessibility, it is a convenient place to view the consequences of congenital and acquired diseases which affect it directly or indirectly. Skin appendages are also useful indicators of metabolic disease. The hair, because of the slow rate at which it is normally shed, can be used as a calendar recording metabolic events several years back. Hair roots are used as easily obtainable material for detection of inborn errors of metabolism, including heterozygote identification in Fabry's and other disease (de Bruyn et al. 1979) . There is a nonspecific slowing of the rate of nail growth in sickness, and transverse grooves give an indication of the time of this; sweat gland electrolyte concentrations change in pathological conditions, including fibrocystic disease: sebum excretion rate is altered not only in acne but also by a number of metabolic and hormonal abnormalities, and this easily measured function can be used as an index of their progression and response to treatment. There is no simple relationship between sebaceous gland grease and dietary fat, and the layman's concept of what he eats 'coming out in the skin' is not an acceptable one. Sebaceous gland metabolism is, nevertheless irrevocably tied up with fat metabolism in general: the useof retinoids, like 13-cis-retinoic acid, to reduce sebum excretion rate in acne can have adverse effects on serum lipids (Lyons et al. 1982) , and this illustrates how powerful the metabolic consequences of some of the drugs now used for skin disease can be.
The skin needs proteins, essential fatty acids, minerals and vitamins in order to maintain its structure and function, and deficiency or abnormal metabolism of these will lead to disease. While the effects on the skin of kwashiorkor and pellagra have been known for a long time, techniques introduced into medicine relatively recently, like small bowel bypass and elemental diets, have led to an increase in deficiency diseases that were previously rare. Linoleic acid deficiency after extensive small bowel resection produces dry, scaly skin which can be restored to normal by replacing the essential fatty acid (Prottey et al. 1975) . Acquired ichthyosis and 'crazy paving' eczema, secondary to malabsorption from other causes, look similar but do not necessarily have the same explanation. Genetically-determined ichthyoses are probably different again: the placental sulphatase C deficiency found in the mothers of babies with sexlinked ichthyosis (de Groot et al. 1980 ) seems to be a specific to that type, and the connection .between the skin and enzyme abnormality is obscure.
The skin is one of the organs most affected by a shortage of zinc, though rashes from acquired zinc deficiency, which were seen in the early days of elemental diets, are rare now that zinc is added to the feeds. Experimentally it is established that the metal is necessary for wound healing, but its clinical use in leg ulcers has been disappointing. Serum concentrations of zinc are certainly low in some patients with leg ulcers as well as in other chronic disease: skin levels on the other hand are not reduced (Dachowski et al. 1975 ) and serum levels do not correlate with whole body zinc (Hawkins et al. 1976) .
Acrodermatitis enteropathica is a geneticallydetermined disease in which zinc absorption is impaired. It is inherited as an autosomal recessive trait. It is very important to diagnose, because untreated it is fatal, while treatment with zinc by mouth results in return to complete normality. The disease usually starts at the time of weaning, breast milk apparently containing a ligand which protects against it. Blisters or erosions with secondary infection, often with Candida albicans, occur round the mouth, fingernails and anus, and other features include diarrhoea, hair loss and 'failure to thrive'. The precise nature of the inherited defect is not known, but one theory is that an abnormal small peptide chelates zinc in the bowel and decreases its absorption (Moynahan 1974): large amounts of oral zinc override this and ensure that adequate amounts are absorbed.
Other genetically-determined diseases which affect the skin are less satisfactory to treat, though moderate success is possible with phenylketonuria if it is diagnosed early enough. The eczema and pigmentary changes may give a clue to diagnosis, but other signs and routine screening tests are more likely to he important; other amino acid abnormalities, including Hartnup disease, are associated with eczema, but again skin signs are not the most important in diagnosis; the easily fractured hair, from trichorrhexis nodosa, in arginosuccinic aciduria, and the kinky hair of Menkes' syndrome are rarely features on which diagnosis rests; in the mucopolysaccharidoses too the skin is only one of the many sites of obvious disease. By contrast, the cutaneous 'angiokeratomata' of Fabry's disease can be extremely helpful diagnostically, though they usually do not develop until young adult life: as a rule dermatologists have no difficulty in distinguishing them from other angiokeratomata, though clinical disease with many features of Fabry's disease has been reported without the characteristic alphagalactosidase A deficiency (Epinette et al. 1973) . In some serious inherited diseases it may seem more appropriate to make the diagnosis in utero, and there is a precedent in the severe forms of epidermolysis bullosa for diagnosis by fetal visualization and skin biopsy (Eady et al. 1982) . There is scope for extension of these procedures to other metabolic diseases which involve the skin, though what should be done with the information once it has been obtained is an ethical as well as a medical matter.
Because of its unique position, the skin and its metabolism are much influenced by light. Good effects like vitamin D synthesis, and bad effects like tumour production in xeroderma pigmentosum, have already been mentioned. Blue light is used to reduce hyperbilirubinaemia in babies, though the metabolic reaction involved is not fully understood (Brown & McDonagh 1980) . Another therapeutic use of light is in photochemotherapy orPUVA (Parrish et al. 1974) , where photoadducts are formed between psoralens and thymine bases of DNA only in the presence of long-wave ultraviolet light (UVA). This was the theoretical basis for introducing PUVA as a very effective treatment for psoriasis, though it is uncertain that the mechanism of its action is necessarily related to this effect on DNA.
Porphyria is probably the commonest group of metabolic diseases in which the skin is affected by light, in this case long-wave ultraviolet. Most types of porphyria can now be explained on the basis of specific enzyme defects: these are usually genetically determined, but in some types poisons, including alcohol as well as drugs, iron overload and liver function abnormalities contribute to the production of clinical disease; rarely hepatic tumours secrete porphyrins in large enough amounts to produce photosensitivity. There is no explanation of the different skin changes, including blisters, friable skin, scars, milia, scleroderma, oedema, burning, hypertrichosis, which occur in different combinations in the different porphyrias (Magnus 1980) . Acute intermittent porphyria is the one type in which the skin remains unaffected and here neither porphyrins nor their precursors appear in the skin.
It is apparent that there are many cutaneous aspects of metabolic disease. Occasionally, information which is clinically important to the patient as a whole can be obtained at a time when other signs are not apparent by nothing more complicated than looking at the skin or its appendages. Once the skin signs have been elicited it is of course necessary to decide whether they are primary, secondary to internal disease, part of a disease process which is common to the skin and other organs, or merely a marker of indirectly-related disease which happens, usually for a genetic reason, to be associated.
Exciting developments in the understanding of several groups of metabolic diseases which involve the skin. have taken place over the past few years. Usually this has involved the identification of specific enzyme defects. It is disappointing, but hardly surprising, that advances in diagnosis have not been accompanied by equal advances in treatment. Isolated reports of clinical and biochemical improvement after renal or bone marrow transplants in Fabry's disease (Hobbs 1981 , Clement et al. 1982 and after bone marrow transplants in Hurler's syndrome (Hobbs 1981) , interesting though they are, do not at the moment offer much hope for those afflicted with these and similar metabolic diseases.
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